Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease

A fixed-dose inhaled corticosteroid/long-acting β(2)-agonist (ICS/LABA) combination of extrafine beclometasone dipropionate and formoterol fumarate (BDP/FF) has been recently approved for use in chronic obstructive pulmonary disease (COPD). Small airway inflammation and remodelling are cardinal feat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:NPJ Prim Care Respir Med
Autori principali: Singh, Dave, Corradi, Massimo, Spinola, Monica, Petruzzelli, Stefano, Papi, Alberto
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2016
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910970/
https://ncbi.nlm.nih.gov/pubmed/27309985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npjpcrm.2016.30
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi